Avanos Medical (AVNS) stock is up more than 17% over the past 30 days. AVNS stock is down -38.40% over the last 12 months, and the average rating from Wall Street analysts is a Moderate Buy. Stock Score Report, InvestorsObserver’s proprietary scoring system, gives AVNS stock a score of 38 out of a possible 100.
That score is chiefly influenced by a fundamental score of 18. In addition to the average rating from Wall Street analysts, AVNS stock has a mean target price of $47.83. This means analysts expect the stock to gain 22.77% over the next 12 months. AVNS’s score also includes a long-term technical score of 45. The short-term technical score for AVNS is 50.
What’s Happening with AVNS Stock Today
Avanos Medical Inc (AVNS) stock is higher by 6.07% while the S&P 500 is higher by 1.25% as of 3:50 PM on Wednesday, Oct 9. AVNS is higher by $2.23 from the previous closing price of $36.73 on volume of 789,775 shares. Over the past year the S&P 500 has risen 1.55% while AVNS is down -38.40%. AVNS lost -$0.26 per share in the over the last 12 months.